At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 25 enrolled
Drug / intervention
Adipose derived stem cellsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
In Brief
A Phase 2 clinical trial evaluating Adipose derived stem cells for Diabetic Foot and 2 related conditions. Completed, enrolled 25 participants across 1 site.
Detailed Summary
Our study aims to explore the effects of Adipose Derived Stem Cells (ASCs) on chronic wounds.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot, Venous Ulcer, Pressure Ulcer
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedMar 2014
Primary CompletionSep 2015
Study CompletionSep 2019
TodayJul 2026
First PostedMar 20, 2014
Enrollment StartSep 1, 2013
Primary CompletionSep 1, 2015
Study CompletionSep 9, 2019
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 12.3 years ago
Interventions
Adipose derived stem cellsdrug
ASCs harvested from autologous lipoaspirate